TVARDI THERAPEUTICS, INC. Operating Expenses
TVARDI THERAPEUTICS, INC. (TVRD) reported Operating Expenses of $6.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $6.63M, a 25.26% decline year-over-year.
- TVARDI THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $7.05M, a 61.94% increase year-over-year.
- TVARDI THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $7.59M, a 29.76% decline year-over-year.
- TVARDI THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $5.94M, a 4.62% increase year-over-year.
- TVARDI THERAPEUTICS, INC. operating expenses for fiscal 2025 was $26.75M, a 4.84% decline from fiscal 2024.
- TVARDI THERAPEUTICS, INC. operating expenses for fiscal 2024 was $28.11M, a 80.27% decline from fiscal 2023.
- TVARDI THERAPEUTICS, INC. operating expenses for fiscal 2023 was $142.46M, a 10.09% increase from fiscal 2022.
- TVARDI THERAPEUTICS, INC. operating expenses for fiscal 2022 was $129.40M, a 15.42% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.63M 10-Q · filed 2026-08-14 | $13.68M 10-Q · filed 2026-08-14 | $21.27M derived: sum of 3 quarters · filed 2026-08-14 | $27.20M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $7.05M 10-Q · filed 2026-05-08 | $14.64M derived: sum of 2 quarters · filed 2026-05-08 | $20.58M derived: sum of 3 quarters · filed 2026-05-08 | $29.45M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $13.53M derived: sum of 2 quarters · filed 2026-03-31 | $22.39M derived: sum of 3 quarters · filed 2026-08-14 | $26.75M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $5.94M 10-Q · filed 2025-11-13 | $14.81M derived: sum of 2 quarters · filed 2026-08-14 | $19.16M 10-Q · filed 2025-11-13 | $29.96M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $8.87M 10-Q · filed 2026-08-14 | $13.22M 10-Q · filed 2026-08-14 | $24.02M derived: sum of 3 quarters · filed 2026-08-14 | $29.70M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $4.35M 10-Q · filed 2026-05-08 | $4.96M 10-Q · filed 2025-05-13 | $15.16M derived: sum of 2 quarters · filed 2026-05-08 | $20.83M derived: sum of 3 quarters · filed 2026-05-08 | $28.01M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $16.48M derived: sum of 2 quarters · filed 2026-03-31 | $23.66M derived: sum of 3 quarters · filed 2026-03-31 | $28.11M 10-K · filed 2026-03-31 | $65.52M 10-K · filed 2025-03-11 | |||
| 2024-09-30 | $5.68M 10-Q · filed 2025-11-13 | $8.54M 10-Q · filed 2024-11-14 | $12.86M derived: sum of 2 quarters · filed 2025-11-13 | $17.30M 10-Q · filed 2025-11-13 | $58.64M 10-Q · filed 2024-11-14 | $80.27M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $7.18M 10-Q · filed 2025-08-14 | $18.30M 10-Q · filed 2024-08-14 | $11.63M 10-Q · filed 2025-08-14 | $50.10M 10-Q · filed 2024-08-14 | $74.59M derived: sum of 3 quarters · filed 2025-08-14 | $108.36M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $31.80M 10-Q · filed 2025-05-13 | $67.41M derived: sum of 2 quarters · filed 2025-05-13 | $101.18M derived: sum of 3 quarters · filed 2025-05-13 | $140.45M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $35.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $69.38M derived: sum of 2 quarters · filed 2025-03-11 | $108.65M derived: sum of 3 quarters · filed 2025-03-11 | $142.46M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $33.76M 10-Q · filed 2024-11-14 | $73.04M derived: sum of 2 quarters · filed 2024-11-14 | $106.85M 10-Q · filed 2024-11-14 | $141.42M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | $39.27M 10-Q · filed 2024-08-14 | $73.09M 10-Q · filed 2024-08-14 | $107.66M derived: sum of 3 quarters · filed 2025-03-11 | $142.31M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | $33.81M 10-Q · filed 2024-05-13 | $68.38M derived: sum of 2 quarters · filed 2025-03-11 | $103.04M derived: sum of 3 quarters · filed 2025-03-11 | $130.52M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | $34.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $69.23M derived: sum of 2 quarters · filed 2025-03-11 | $96.70M derived: sum of 3 quarters · filed 2025-03-11 | $129.40M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | $34.66M 10-Q · filed 2023-11-13 | $62.13M derived: sum of 2 quarters · filed 2023-11-13 | $94.83M 10-Q · filed 2023-11-13 | $129.18M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | $27.48M 10-Q · filed 2023-08-07 | $60.18M 10-Q · filed 2023-08-07 | $94.52M derived: sum of 3 quarters · filed 2024-03-06 | $115.92M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-03-31 | $32.70M 10-Q · filed 2023-05-15 | $67.04M derived: sum of 2 quarters · filed 2024-03-06 | $88.44M derived: sum of 3 quarters · filed 2024-03-06 | $119.32M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2021-12-31 | $34.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $55.74M derived: sum of 2 quarters · filed 2024-03-06 | $86.61M derived: sum of 3 quarters · filed 2024-03-06 | $112.11M 10-K · filed 2024-03-06 | ||||
| 2021-09-30 | $21.40M 10-Q · filed 2022-11-07 | $52.27M derived: sum of 2 quarters · filed 2022-11-07 | $77.77M 10-Q · filed 2022-11-07 | $111.57M derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $30.88M 10-Q · filed 2022-08-08 | $56.37M 10-Q · filed 2022-08-08 | $90.17M derived: sum of 3 quarters · filed 2022-08-08 | $116.46M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $25.50M 10-Q · filed 2022-05-09 | $59.30M derived: sum of 2 quarters · filed 2022-05-09 | $85.58M derived: sum of 3 quarters · filed 2022-05-09 | $117.10M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $33.80M 10-K · filed 2021-02-25 | $60.09M derived: sum of 2 quarters · filed 2021-11-08 | $91.60M derived: sum of 3 quarters · filed 2021-11-08 | $129.70M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $26.29M 10-Q · filed 2021-11-08 | $57.80M derived: sum of 2 quarters · filed 2021-11-08 | $95.90M 10-Q · filed 2021-11-08 | $130.38M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $31.52M 10-Q · filed 2021-08-09 | $69.61M 10-Q · filed 2021-08-09 | $104.09M derived: sum of 3 quarters · filed 2021-08-09 | $144.31M derived: sum of 4 quarters · filed 2021-08-09 | ||||
| 2020-03-31 | $38.09M 10-Q · filed 2021-05-10 | $72.58M derived: sum of 2 quarters · filed 2021-05-10 | $112.79M derived: sum of 3 quarters · filed 2021-05-10 | $142.14M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $34.48M 10-K · filed 2021-02-25 | $74.70M derived: sum of 2 quarters · filed 2021-02-25 | $104.05M derived: sum of 3 quarters · filed 2021-02-25 | $131.56M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $40.22M 10-K · filed 2021-02-25 | $69.57M derived: sum of 2 quarters · filed 2021-02-25 | $97.08M 10-Q · filed 2020-11-09 | $124.59M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $29.35M 10-K · filed 2021-02-25 | $56.87M 10-Q · filed 2020-08-10 | $84.38M derived: sum of 3 quarters · filed 2021-02-25 | $109.91M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $27.52M 10-K · filed 2021-02-25 | $55.03M derived: sum of 2 quarters · filed 2021-02-25 | $80.56M derived: sum of 3 quarters · filed 2021-02-25 | $101.24M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $27.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $53.04M derived: sum of 2 quarters · filed 2021-02-25 | $73.73M derived: sum of 3 quarters · filed 2021-02-25 | $90.85M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $25.53M 10-Q · filed 2019-11-05 | $46.22M derived: sum of 2 quarters · filed 2019-11-05 | $63.34M 10-Q · filed 2019-11-05 | $77.91M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $20.69M 10-Q · filed 2019-08-07 | $37.81M 10-Q · filed 2019-08-07 | $52.38M derived: sum of 3 quarters · filed 2020-02-27 | $65.34M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $17.12M 10-Q · filed 2019-05-07 | $31.70M derived: sum of 2 quarters · filed 2020-02-27 | $44.65M derived: sum of 3 quarters · filed 2020-02-27 | $54.28M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $27.53M derived: sum of 2 quarters · filed 2020-02-27 | $37.16M derived: sum of 3 quarters · filed 2020-02-27 | $60.40M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $12.96M 10-Q · filed 2018-11-06 | $22.59M derived: sum of 2 quarters · filed 2018-11-06 | $45.83M 10-Q · filed 2018-11-06 | $68.14M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $9.63M 10-Q · filed 2018-08-07 | $32.87M 10-Q · filed 2018-08-07 | $55.18M derived: sum of 3 quarters · filed 2019-03-12 | $66.96M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $23.24M 10-Q · filed 2018-05-09 | $45.55M derived: sum of 2 quarters · filed 2019-03-12 | $57.32M derived: sum of 3 quarters · filed 2019-03-12 | $70.73M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $22.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $34.09M derived: sum of 2 quarters · filed 2019-03-12 | $47.49M derived: sum of 3 quarters · filed 2019-03-12 | $58.49M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $11.77M 10-Q · filed 2017-11-02 | $25.18M derived: sum of 2 quarters · filed 2017-11-02 | $36.17M 10-Q · filed 2017-11-02 | $45.90M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $13.40M 10-Q · filed 2017-08-03 | $24.40M 10-Q · filed 2017-08-03 | $34.13M derived: sum of 3 quarters · filed 2018-03-15 | $41.58M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $10.99M 10-Q · filed 2017-05-04 | $20.72M derived: sum of 2 quarters · filed 2018-03-15 | $28.17M derived: sum of 3 quarters · filed 2018-03-15 | $34.78M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $9.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $17.18M derived: sum of 2 quarters · filed 2018-03-15 | $23.78M derived: sum of 3 quarters · filed 2018-03-15 | $28.99M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $7.45M 10-Q · filed 2016-11-04 | $14.05M derived: sum of 2 quarters · filed 2016-11-04 | $19.26M 10-Q · filed 2016-11-04 | $24.51M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | $6.61M 10-Q · filed 2016-08-04 | $11.81M 10-Q · filed 2016-08-04 | $17.06M derived: sum of 3 quarters · filed 2017-03-10 | $24.79M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | $5.21M 10-Q · filed 2016-05-05 | $10.46M derived: sum of 2 quarters · filed 2017-03-10 | $18.18M derived: sum of 3 quarters · filed 2017-03-10 | $22.86M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $12.98M derived: sum of 2 quarters · filed 2017-03-10 | $17.65M derived: sum of 3 quarters · filed 2017-03-10 | $21.25M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $7.73M 10-Q · filed 2015-11-09 | $12.40M derived: sum of 2 quarters · filed 2015-11-09 | $16.00M 10-Q · filed 2015-11-09 | $19.08M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $4.67M 10-Q · filed 2015-08-10 | $8.27M 10-Q · filed 2015-08-10 | $11.35M derived: sum of 3 quarters · filed 2016-03-11 | $15.91M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $3.60M 10-Q · filed 2015-05-12 | $6.68M derived: sum of 2 quarters · filed 2016-03-11 | $11.24M derived: sum of 3 quarters · filed 2016-03-11 | $14.29M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $7.64M derived: sum of 2 quarters · filed 2016-03-11 | $10.69M derived: sum of 3 quarters · filed 2016-03-11 | $12.20M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $4.56M 10-Q · filed 2014-11-10 | $7.61M derived: sum of 2 quarters · filed 2014-11-10 | $9.12M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $3.05M 10-Q · filed 2014-08-07 | $4.56M 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | $1.51M 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | $7.43M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |